• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化的实验室标志物及其临床意义。

Laboratory markers of platelet activation and their clinical significance.

作者信息

Michelson A D, Furman M I

机构信息

Center for Platelet Function Studies, Department of Pediatrics, University of Massachusetts Medical School, Worcester 01655, USA.

出版信息

Curr Opin Hematol. 1999 Sep;6(5):342-8. doi: 10.1097/00062752-199909000-00012.

DOI:10.1097/00062752-199909000-00012
PMID:10468151
Abstract

Whole blood flow cytometry is a powerful new laboratory technique for assessment of platelet activation and function. Flow cytometry can be used to measure platelet hyperreactivity, circulating activated platelets, leukocyte-platelet aggregates, and procoagulant platelet-derived microparticles in a number of clinical settings, including acute coronary syndromes, angioplasty, cardiopulmonary bypass, acute cerebrovascular ischemia, peripheral vascular disease, diabetes mellitus, preeclampsia, and Alzheimer's disease. Clinical applications of whole blood flow cytometric assays of platelet function in these diseases may include identification of patients who would benefit from additional antiplatelet therapy and prediction of ischemic events. Circulating monocyte-platelet aggregates appear to be a more sensitive marker of in vivo platelet activation than circulating P-selectin-positive platelets. Flow cytometry can also be used in the following clinical settings: monitoring of glycoprotein IIb-IIIa antagonist therapy, diagnosis of inherited deficiencies of platelet surface glycoproteins, diagnosis of storage pool disease, diagnosis of heparin-induced thrombocytopenia, and measurement of the rate of thrombopoiesis.

摘要

全血流式细胞术是一种用于评估血小板活化和功能的强大新实验室技术。流式细胞术可用于在多种临床环境中测量血小板高反应性、循环活化血小板、白细胞 - 血小板聚集体和促凝血血小板衍生微粒,这些临床环境包括急性冠状动脉综合征、血管成形术、体外循环、急性脑血管缺血、外周血管疾病、糖尿病、先兆子痫和阿尔茨海默病。在这些疾病中,全血流式细胞术检测血小板功能的临床应用可能包括识别可能从额外抗血小板治疗中获益的患者以及预测缺血事件。循环单核细胞 - 血小板聚集体似乎是体内血小板活化比循环P - 选择素阳性血小板更敏感的标志物。流式细胞术还可用于以下临床环境:监测糖蛋白IIb - IIIa拮抗剂治疗、诊断血小板表面糖蛋白遗传性缺陷、诊断储存池病、诊断肝素诱导的血小板减少症以及测量血小板生成率。

相似文献

1
Laboratory markers of platelet activation and their clinical significance.血小板活化的实验室标志物及其临床意义。
Curr Opin Hematol. 1999 Sep;6(5):342-8. doi: 10.1097/00062752-199909000-00012.
2
Evaluation of platelet function by flow cytometry.通过流式细胞术评估血小板功能。
Methods. 2000 Jul;21(3):259-70. doi: 10.1006/meth.2000.1006.
3
Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.血小板活化作为糖蛋白IIb/IIIa抑制剂诱导血小板减少症的潜在机制。
Am J Cardiol. 1999 Sep 1;84(5):519-24. doi: 10.1016/s0002-9149(99)00370-7.
4
Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.糖蛋白IIb/IIIa抑制剂对体外CD62p表达、血小板聚集体及微粒的影响。
J Lab Clin Med. 2000 Mar;135(3):247-55. doi: 10.1067/mlc.2000.104907.
5
Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.冠状动脉支架置入术后糖蛋白IIb-IIIa受体拮抗剂对血小板膜糖蛋白的影响。
Thromb Haemost. 1998 Dec;80(6):994-1001.
6
Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.体外循环期间一氧化氮气体与伊洛前列素联合应用可减轻血小板功能障碍:一项初步临床研究。
J Thorac Cardiovasc Surg. 2005 Apr;129(4):782-90. doi: 10.1016/j.jtcvs.2004.06.049.
7
Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.在体外循环期间,通过糖蛋白IIb/IIIa复合物拮抗剂和阿加曲班进行的药理学血小板麻醉。
J Thorac Cardiovasc Surg. 2003 Aug;126(2):428-35. doi: 10.1016/s0022-5223(02)73288-1.
8
Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets.糖蛋白IIb/IIIa拮抗剂对肝素诱导的血小板血清激活的影响。
Thromb Res. 1997 Nov 1;88(3):271-81. doi: 10.1016/s0049-3848(97)00254-5.
9
Platelet activation and progression to complications.血小板活化与并发症进展。
Rev Cardiovasc Med. 2006 Spring;7(2):75-81.
10
Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.氯吡格雷与阿司匹林联合用药对比单用阿司匹林对心力衰竭患者血小板聚集及主要受体表达的影响:氯吡格雷用于治疗充血性心力衰竭(PLUTO-CHF)试验
Am Heart J. 2003 Oct;146(4):713-20. doi: 10.1016/S0002-8703(03)00260-6.

引用本文的文献

1
Pseudothrombocytopenia and other conditions associated with spuriously low platelet counts.假性血小板减少症及其他与血小板计数假性降低相关的情况。
Haematologica. 2025 Aug 1;110(8):1677-1692. doi: 10.3324/haematol.2024.286234. Epub 2025 Mar 27.
2
Bystander effect of SARS-CoV-2 spike protein on human monocytic THP-1 cell activation and initiation of prothrombogenic stimulus representing severe COVID-19.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白对人单核细胞系THP-1细胞激活及代表重症新型冠状病毒肺炎的促血栓形成刺激启动的旁观者效应
J Inflamm (Lond). 2022 Dec 30;19(1):28. doi: 10.1186/s12950-022-00325-8.
3
Aspirin for the Primary Prevention of Cardiovascular Disease: Time for a Platelet-Guided Approach.
阿司匹林用于心血管疾病一级预防:是时候采用血小板指导的方法了。
Arterioscler Thromb Vasc Biol. 2022 Oct;42(10):1207-1216. doi: 10.1161/ATVBAHA.122.318020. Epub 2022 Sep 1.
4
Platelet Toll-Like-Receptor-2 and -4 Mediate Different Immune-Related Responses to Bacterial Ligands.血小板Toll样受体2和4介导对细菌配体的不同免疫相关反应。
TH Open. 2022 Jul 11;6(3):e156-e167. doi: 10.1055/a-1827-7365. eCollection 2022 Jul.
5
Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA COVID-19 vaccine.与对 BNT162b2 mRNA COVID-19 疫苗快速反应相关的血小板和免疫特征。
J Thromb Haemost. 2022 Apr;20(4):961-974. doi: 10.1111/jth.15648. Epub 2022 Jan 26.
6
Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects.新型冠状病毒肺炎相关血栓形成的基础:分子与细胞层面
Front Cardiovasc Med. 2021 Dec 17;8:785738. doi: 10.3389/fcvm.2021.785738. eCollection 2021.
7
Shear-mediated platelet activation in the free flow II: Evolving mechanobiological mechanisms reveal an identifiable signature of activation and a bi-directional platelet dyscrasia with thrombotic and bleeding features.自由流动状态下剪切力介导的血小板激活II:不断演变的力学生物学机制揭示了可识别的激活特征以及具有血栓形成和出血特征的双向血小板异常。
J Biomech. 2021 Jun 23;123:110415. doi: 10.1016/j.jbiomech.2021.110415. Epub 2021 Apr 27.
8
Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state.比较蛋白质组学揭示了与血小板激活状态相关的意想不到的定量磷酸化差异。
Sci Rep. 2019 Dec 12;9(1):19009. doi: 10.1038/s41598-019-55391-5.
9
Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis.JNJ-64179375 抑制 exosite1 凝血酶可抑制血栓形成的人体血栓转化模型。
Cardiovasc Res. 2019 Mar 1;115(3):669-677. doi: 10.1093/cvr/cvy227.
10
Glycoprotein IIb/IIIa receptor imaging with F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study.采用F-GP1正电子发射断层扫描术对糖蛋白IIb/IIIa受体进行成像用于急性静脉血栓栓塞症:一项开放标签、非随机、首次人体1期研究。
J Nucl Med. 2018 Jun 29;60(2):244-9. doi: 10.2967/jnumed.118.212084.